Percheron Therapeutics Ltd
(ASX) PER
Percheron Therapeutics Ltd Financials at a Glance
Market Cap
$6.09M
Revenue (TTM)
$0.00
Net Income (TTM)
$25.20M
EPS (TTM)
$-0.01
P/E Ratio
-0.47
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Price
$0.01
Volume
210,198
Open
$0.00
Price
$0.01
Volume
210,198
Open
$0.00
Previous Close
$0.01
Daily Range
$0.00 - $0.01
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Price
$0.01
Volume
210,198
Open
$0.00
Previous Close
$0.01
Daily Range
$0.00 - $0.01
52-Week Range
$0.00 - $0.01
PER News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Percheron Therapeutics Ltd
Industry
Pharmaceuticals
Sector
Health CareEmployees
4
CEO
James Stuart Garner, PhD, MBA
Website
www.PercheronTx.comHeadquarters
Melbourne, VIC 3000, AU
PER Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-85%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-2.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.09M
Shares Outstanding
1.52B
Volume
210.20K
Short Interest
0.00%
Avg. Volume
835.89K
Financials (TTM)
Gross Profit
$67.98K
Operating Income
$16.71M
EBITDA
$16.27M
Operating Cash Flow
$15.64M
Capital Expenditure
$7.24K
Free Cash Flow
$15.65M
Cash & ST Invst.
$10.17M
Total Debt
$25.86K
Percheron Therapeutics Ltd Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$19.12K
+59.7%
Gross Margin
0.00%
N/A
Market Cap
$6.09M
N/A
Market Cap/Employee
$761.20K
N/A
Employees
8
N/A
Net Income
$3.11M
+34.5%
EBITDA
$3.16M
+42.3%
Quarterly Fundamentals
Net Cash
$4.45M
-74.1%
Accounts Receivable
$97.33K
-96.3%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$10.68K
-33.8%
Return on Assets
-1.20%
N/A
Return on Invested Capital
-1.58%
N/A
Free Cash Flow
$2.62M
+46.0%
Operating Cash Flow
$2.61M
+46.0%